FDA's Top Drug Regulator Resigns
Digest more
A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts ...
The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some ...
Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...
More than 580,000 bottles of prazosin hydrochloride capsules have been recalled after tests found potential cancer-causing ...
The Trump administration is proposing changes to Food and Drug Administration guidelines that would make it less expensive ...
Investor's Business Daily on MSN
Sarepta Crashes After Two Muscular Dystrophy Drugs Fail Confirmatory Tests
Sarepta stock crashed late Monday after the biotech company said two of its muscular dystrophy drugs failed their ...
New professional guidance to the nation's pediatricians advises against using a drug in children with autism that many families are clamoring for after it was hyped by federal officials.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback